We are live on ! Find out more
IART icon

Integra LifeSciences
IART

223 hedge funds and large institutions have $2.96B invested in Integra LifeSciences in 2016 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 95 increasing their positions, 61 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

477% more call options, than puts

Call options by funds: $12M | Put options by funds: $2.08M

185.69% more ownership

Funds ownership: 0% → 185.69% (+186%)

56% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 61

8% more capital invested

Capital invested by funds: $2.75B → $2.96B (+$211M)

5% less funds holding

Funds holding: 234 → 223 (-11)

22% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 41

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
223
Holders Change
-11
Holders Change %
-4.7%
% of All Funds
5.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
32
Increased
95
Reduced
61
Closed
41
Calls
$12M
Puts
$2.08M
Net Calls
+$9.9M
Net Calls Change
+$1.89M

Top Buyers

1
Invesco
Invesco
Georgia
+$50.1M
2
JHIU
Janus Henderson Investors US
Colorado
+$41.6M
3
EAM
Eagle Asset Management
Florida
+$35.7M
4
CIP
Champlain Investment Partners
Vermont
+$27.9M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$21.4M

Top Sellers

1
WHG
Westwood Holdings Group
Texas
-$36.6M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$35.3M
3
CCI
Columbus Circle Investors
-$25.7M
4
SAM
Silvercrest Asset Management
New York
-$20.3M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$14.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
151
ProShare Advisors
Maryland
$474K +$158K +3,888 +54%
B
152
Barings
North Carolina
$472K – – –
PFA
153
Pure Financial Advisors
California
$467K +$1.54K +38 +0.3%
ECM
154
ETrade Capital Management
Virginia
$457K +$135K +3,324 +45%
SB
155
Suntrust Banks
Georgia
$432K +$81.9K +2,016 +25%
GC
156
Guggenheim Capital
Illinois
$380K -$660K -16,244 -65%
WG
157
Winton Group
United Kingdom
$379K +$359K +8,832 New
AB
158
Amalgamated Bank
New York
$344K +$42.1K +1,036 +15%
CCA
159
Conestoga Capital Advisors
Pennsylvania
$343K – – –
NIC
160
Northwest Investment Counselors
Oregon
$338K -$25.6K -630 -7%
PI
161
PineBridge Investments
New York
$332K +$5.28K +130 +2%
PPCM
162
Pillar Pacific Capital Management
California
$300K – – –
WB
163
WesBanco Bank
West Virginia
$300K – – –
DekaBank Deutsche Girozentrale
164
DekaBank Deutsche Girozentrale
Germany
$291K – – –
FA
165
FDx Advisors
Illinois
$286K +$263K +6,474 +96%
N
166
Natixis
France
$286K +$271K +6,668 New
SOADOR
167
State of Alaska Department of Revenue
Alaska
$277K +$263K +6,460 New
NBC
168
Neuberger Berman Canada
Ontario, Canada
$266K +$504K +12,404 New
AAM
169
Aureus Asset Management
Massachusetts
$257K – – –
AssetMark Inc
170
AssetMark Inc
California
$257K +$406K +10,000 +501%
BC
171
Burney Company
Virginia
$249K -$28.5K -700 -11%
LPL Financial
172
LPL Financial
California
$244K +$233K +5,738 New
SG Americas Securities
173
SG Americas Securities
New York
$235K -$402K -9,896 -64%
GCP
174
GSA Capital Partners
United Kingdom
$224K -$6.02K -148 -3%
AIP
175
Ameritas Investment Partners
Nebraska
$224K – – –
5 6
7
8 9

IART Hedge Fund Activity: Q4 2016 in Review

223 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2016, worth a combined $2.96B — up 7.7% from $2.75B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of IART and 32 opened new positions — a net loss of 9 holders — while 61 trimmed existing stakes and 95 added.

The largest buyer was Invesco, adding an estimated $50.1M. The largest seller was Westwood Holdings Group, cutting an estimated $36.6M.

  • 223 institutional investors held Integra LifeSciences (IART) as of Q4 2016, down from 234 in Q3 2016.
  • Funds reported $2.96B of Integra LifeSciences stock for Q4 2016, up 7.7% quarter-over-quarter.
  • 32 funds opened new Integra LifeSciences positions in Q4 2016 and 41 closed out, a net change of -9 holders.
  • The largest Integra LifeSciences buyer in Q4 2016 was Invesco, an estimated $50.1M added.
  • The largest Integra LifeSciences seller in Q4 2016 was Westwood Holdings Group, an estimated $36.6M sold.

Based on aggregated 13F filings for Q4 2016.